Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 14, 2019

Total Value: $174M (100.0% shares, 0.0% debt)

Holdings (30)

VNDA VANDA PHARMACEUTICALS INC 13.3%
Value $23.19M Shares 1,260,288 Share Price $18.40 * Est. Cost/Share $21.40 Unrealized @ Report Date +6.5%
— AMARIN CORP PLC -ADR 11.3%
Value $19.65M Shares 946,379 Share Price $20.76 Est. Cost/Share $3.01 Unrealized @ Report Date —
LGND LIGAND PHARMACEUTICALS 10.8%
Value $18.86M Shares 150,000 Share Price $125.71 * Est. Cost/Share $75.76 Unrealized @ Report Date 0.0%
— NEOS THERAPEUTICS INC 6.8%
Value $11.78M Shares 4,511,504 Share Price $2.61 Est. Cost/Share $1.88 Unrealized @ Report Date —
— APOLLO ENDOSURGERY INC 5.6%
Value $9.651M Shares 2,580,518 Share Price $3.74 Est. Cost/Share $4.60 Unrealized @ Report Date —
— BIODELIVERY SCIENCES INTL 4.7%
Value $8.159M Shares 1,539,437 Share Price $5.30 Est. Cost/Share $2.54 Unrealized @ Report Date —
— HTG MOLECULAR DIAGNOSTICS 4.1%
Value $7.089M Shares 2,835,786 Share Price $2.50 Est. Cost/Share $2.67 Unrealized @ Report Date —
— ADAMAS PHARMACEUTICALS INC 4.0%
Value $6.999M Shares 984,329 Share Price $7.11 Est. Cost/Share $7.11 Unrealized @ Report Date —
CPIX CUMBERLAND PHARMACEUTICALS 4.0%
Value $6.983M Shares 1,201,975 Share Price $5.81 Est. Cost/Share $5.84 Unrealized @ Report Date -0.6%
— ALIMERA SCIENCES INC 4.0%
Value $6.873M Shares 6,483,610 Share Price $1.06 Est. Cost/Share $1.18 Unrealized @ Report Date —
— AEGERION PHARMACEUTICALSAEGR 2 08/15/19 3.5%
Value $6.032M Shares 9,000,000 Share Price $0.67 Est. Cost/Share $0.67 Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 3.3%
Value $5.811M Shares 60,840 Share Price $95.51 * Est. Cost/Share $89.70 Unrealized @ Report Date 0.0%
— OPHTHOTECH CORP 3.3%
Value $5.746M Shares 4,074,944 Share Price $1.41 Est. Cost/Share $2.69 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 2.2%
Value $3.881M Shares 4,000,000 Share Price $0.97 Est. Cost/Share $3.06 Unrealized @ Report Date —
— OPIANT PHARMACEUTICALS INC 2.2%
Value $3.869M Shares 294,894 Share Price $13.12 Est. Cost/Share $16.22 Unrealized @ Report Date —
— APTEVO THERAPEUTICS INC 2.0%
Value $3.505M Shares 3,894,219 Share Price $0.90 Est. Cost/Share $0.90 Unrealized @ Report Date —
— VIVEVE MEDICAL INC 1.8%
Value $3.199M Shares 3,403,402 Share Price $0.94 Est. Cost/Share $6.92 Unrealized @ Report Date —
XOMA XOMA CORP 1.6%
Value $2.816M Shares 227,430 Share Price $12.38 * Est. Cost/Share $13.68 Unrealized @ Report Date 0.0%
— FOAMIX PHARMACEUTICALS LTD 1.6%
Value $2.738M Shares 730,004 Share Price $3.75 Est. Cost/Share $4.50 Unrealized @ Report Date —
EBS EMERGENT BIOSOLUTIONS INC 1.4%
Value $2.364M Shares 46,800 Share Price $50.51 * Est. Cost/Share $58.99 Unrealized @ Report Date 0.0%
— OXFORD IMMUNOTEC GLOBAL PLC 1.3%
Value $2.192M Shares 127,224 Share Price $17.23 Est. Cost/Share $16.23 Unrealized @ Report Date —
— MATINAS BIOPHARMA HOLDINGS I 1.3%
Value $2.189M Shares 2,008,006 Share Price $1.09 Est. Cost/Share $1.09 Unrealized @ Report Date —
— AFFIMED NV 1.2%
Value $2.124M Shares 505,736 Share Price $4.20 Est. Cost/Share $3.11 Unrealized @ Report Date —
— CHIASMA INC 0.9%
Value $1.56M Shares 300,000 Share Price $5.20 Est. Cost/Share $5.20 Unrealized @ Report Date —
— VERASTEM INC 0.9%
Value $1.48M Shares 500,000 Share Price $2.96 Est. Cost/Share $2.96 Unrealized @ Report Date —
— INTERPACE DIAGNOSTICS GROUP 0.7%
Value $1.147M Shares 1,434,030 Share Price $0.80 Est. Cost/Share $0.80 Unrealized @ Report Date —
DMAC DIAMEDICA THERAPEUTICS INC 0.7%
Value $1.135M Shares 250,000 Share Price $4.54 * Est. Cost/Share $3.61 Unrealized @ Report Date 0.0%
XENE XENON PHARMACEUTICALS INC 0.6%
Value $1.004M Shares 98,860 Share Price $10.16 * Est. Cost/Share $8.48 Unrealized @ Report Date 0.0%
— STRONGBRIDGE BIOPHARMA PLC 0.5%
Value $932K Shares 187,074 Share Price $4.98 Est. Cost/Share $4.98 Unrealized @ Report Date —
COLL COLLEGIUM PHARMACEUTICAL INC 0.5%
Value $909K Shares 60,045 Share Price $15.14 * Est. Cost/Share $16.02 Unrealized @ Report Date 0.0%